News

Summary Available! TB Clinical Trials Consultants Meeting

On November 17 and 18, a TB Clinical Trials Consultants Meeting was held at St. George’s, University of London. The meeting was organized by CDC, CPTR, INTERTB, NIH, and TB Alliance. The meeting was convened to catalog expert opinion on the conduct of Phase 2 and Phase 3 clinical trials in tuberculosis. Sessions included:

  • Session 1: Clinical aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 2: Laboratory aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 3: Analytical aspects of Phase 2 studies measuring sputum mycobacterial load over time
  • Session 4: Clinical aspects of Phase 3 studies
  • Session 5: Laboratory aspects of Phase 3 studies
  • Session 6: Analytical aspects / endpoints of Phase 3 studies

Click here to get the summary of the meeting with all the questions and answers.

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...